Growth of Streptomyces jamaicensis in a low-chloride medium supplemented with NaBr resulted in the biosynthesis of brominated analogues of the natural chlorinated monamycins. Purification of these new compounds was undertaken by Craig countercurrent distribution studies. Diffusion and dilution assays indicated that antibiotic activity of a monamycin was inversely proportional to its unsolvated molecular weight. The bromo analogues were the least active of the series.
The biosynthetic substitution of bromine for chlorine has been achieved in a number of antibiotic substances (3, 6, 8) . After the addition of inorganic bromide to a dechlorinated medium, Streptomyces aureofaciens produced bromotetracycline (3), and Penicillium griseofulvum and P. nigricans produced bromogriseofulvin (6) .
However, formation of the latter could not be induced by using P. patulum (7) , illustrating that such manipulations were strain or species dependent.
Of the 15 monamycin congeners produced by S. jamaicens8, 6 contained chlorine (1) . In view of the earlier successes, attempts were made to induce the formation of the bromo analogues in order to compare their antibacterial activity with the natural compounds and produce a single congener suitable for X-ray analysis. Chloromonamycins GI, G2, and G3 were isomeric (mol wt 711) as were Hi anid H2 (mol wt 725). Chloromonamycin I was a single compound (mol wt 739). The successful incorporation of bromide would produce new compounds having molecular weights of 755/757, 769/771, and 783/785, designated here bromomonamycin 1, 2, and 3, respectively (Table 1) .
MATERIALS AND METHODS
The strain of S. jamaicensis, the composition of the seed medium, the preparation of the inoculum, and the thin-layer chromatographic system employed were all described previously (4). Growth medium. After extensive investigations, a chloride-free medium (CFM) was designed with the following composition: f-alanine, 0.8 g; urea, 0.6 g; glucose, 50 g; CaCO,, 0.5 g; NaH2PO4, 23 mg; Na2HPO4, 7 mg; FeSO4. 7H20, 7 mg; ZnSO 7H20, 7 mg; MgSO4 7H20, 14 mg; (NH4)eMo;,024, 2 mg; MnSO4-4HWO, 2 mg; CuSO4'5H20, 2 mg; and distilled water to 1 liter. Bromide was provided by the addition of 175 mg of NaBr per liter. Various vitamins were added at the outset of the work, but their use was discontinued with little effect on yield. All compounds were of analytical grade.
Cultivation. Conditions employed were similar to those used to produce the natural monamycins (4). Erlenmeyer flasks (250-ml, containing 55 ml of medium per flask) were briefly sterilized at 121 C for 15 min and shaken on an orbital incubator (5-cm diameter throw) at 200 rpm and 26 C. Scale-up to a 120-liter fermenter (New Brunswick Isolation of bromomonamycin. The monamycin produced during several 100-liter fermentations was extracted into light petroleum (boiling point 40 to 60 C) and concentrated to a light butter-colored oil. The oil was subjected to Craig countercurrent distribution in light petroleum (boiling point 60 to 80 C)-methanol-water (10:10:1) for 100 transfers, which removed the bulk of the contaminating impurities and allowed recovery of crude crystalline monamycin from the first five to six tubes. This material was further subjected to 800 transfers in ethylacetate-cyclo- could not be resolved further by thin-layer chromatography. After 2,400 more transfers in the same system, the halogenated compounds were separated into several overlapping bands. Samples from selected tubes within these bands were analyzed by mass spectrometry (Associated Electrical Industries, MS9) to ascertain which contained the bulk of the brominated compounds. The purest fraction, which was rich in congener 769/771, peaked at tube 1,245; fractions containing the other congeners were removed at intervals to facilitate the overall separation. Tubes with similar contents were pooled, and the solid material was recovered for further purification. Determination of biological activity. The large plate assay was described previously (4). The turbidimetric assay employed a mannitol broth (MB) with the following composition: yeast extract (Difco), 2.5 g; Peptone P (Oxoid), 5 g; lactose, 2 g; mannitol, 10 g; NaCl, 5 g; Na2HPO4, 5 g; tap water to 1 liter. The pH was adjusted to 6.8 with 4 M HCI prior to autoclaving at 121 C for 15 min. Monamycin samples were added in ethyl alcohol, the concentration of which did not exceed 1% (vol/vol) in any single tube. Tubes were inoculated with 50 ;uliters of log-phase Staphylococcus aureus (NCTC 6571) and incubated without stirring at 37 C. The bacteriostatic level was taken as the tube showing no turbidity after 48 h of incubation. The bactericidal level was determined by plating out 0.1-ml samples from each tube onto mannitol agar (MB plus 15 g/liter of agar) and observing for the growth of colonies.
RESULTS AND DISCUSSION
In the tetracycline and griseofulvin fermentations (3, 6) , chloride was preferentially incorporated when both chloride and bromide were present in the growth medium. With chloramphenicol, the situation differed, and the bromide competed with the chloride to an extent which depended on the ratio of the two ions in solution (8) . The formation of bromomonamycin paralleled the latter rather than the former case, both chloro-and bromomonamycins being coproduced. Such coproduction presented one of the major problems in this study for, although chromatographic methods readily separated the non-halogenated from the halogenated monamycins, they were inadequate for distinguishing between the brominated and the chlorinated congeners. The method adopted eventually to estimate the relative abundance of the various congeners present in a given sample involved measurement of their respective peak intensities in a mass spectrum of the sample. Although, at best, this procedure was only semiquantitative, it was the only convenient method for the purpose available to us at that time. Upon raising the NaBr level from 70 to 150 mg/liter, the peak height ratio, I769 + IrrM/I25, rose from 0.88 to 1.7, showing a probable doubling in the proportion of bromomonamycin 2 to chloromonamycins H1 and H2. After a series of such studies, an optimum NaBr concentration of 175 mg/liter was adopted for routine use.
By contrast, many experiments were conducted, aimed at reducing the chloride content of the broth, in the hope of eliminating the chloromonamycins. Complex medium "F" used in the routine production of monamycin (4) was dechlorinated either by titration with silver nitrate or by treatment with an ion-exchange resin (Amberlite MB-1). In the latter case, essential cations were restored to the medium in the form of a chloride-free salt solution. The near elimination of chloride by either method caused the formation of chloromonamycins to be almost totally suppressed but, unfortunately, the addition of even high levels of NaBr failed to induce biosynthesis of the brominated congeners.
A similar situation was observed when medium CFM was inoculated with a suspension of mycelial fragments which had been previously washed and suspended in sterile water. Complex seed medium (1 to 1.5 ml) inoculated directly into medium CFM (4) introduced low concentrations of chloride resulting in the coproduction of bromo-and chloromonamycin. Washing the inoculum to reduce chloride to very low levels inhibited the formation of any halogenated compounds. It was concluded, therefore, that low-chloride levels were essential to initiate or maintain the incorporation of bromide.
The best yields obtained after optimization of medium CFM and the fermentation conditions, and using unwashed inoculum, were about 3 g of total monamycin from a single 100-liter fermentation, of which about 15% represented the bromo compounds. This was considerably below the 10 to 15 g/100 liters obtained with medium "F" in the routine production of monamycin.
The above studies were not successful in completely suppressing formation of the chloro compounds. Craig countercurrent separations did allow isolation of the individual brominated compounds, albeit these were still contaminated with small amounts of certain chlorinated congeners. Accurate mass measurements on each compound (Table 1) Confirmation of this residual contamination was also obtained by amino acid analysis of hydrolyzed material (2) . Further purification of bromomonamycin 2 is underway to produce crystalline material suitable for X-ray analysis.
The abundance of each of the natural congeners in the crude monamycin mixture varied considerably (2) . Only traces of monamycins A and E were present and insufficiently isolated to allow determination of the antibacterial activity.
However, the antibacterial activity of the other eight monamycin congeners, including bromomonamycin 2, were compared by the agardiffusion technique (4). The results (Fig. 1) showed decreasing activity with increasing unsolvated molecular weight. Thus, bromomonamycin 2 was the least active of the series, the unhalogenated analogues were the most active, and the chloromonamycins were intermediate. The general trend of this result was confirmed with some of the more abundant congeners by the use of a turbidimetric assay ( on July 5, 2017 by guest http://aac.asm.org/ Downloaded from involvement of the halogen and the alkyl substitutents in the mode of action. It is noteworthy that the one consistently anomalous result in the diffusion assays was due to monamycin C (Fig. 1, mol wt 689 ). This compound is believed to contain the A4-or A5-dehydroderivative of piperazic acid (5) and differs from the other monamycins in possessing a degree of unsaturation. Clarification of these observations may result from the biological and physico-chemical studies at present in progress on the interaction of the monamycins with bacterial cells, erythrocytes, and monovalent cations.
